Difference between revisions of "Team:NUS Singapore-A/Demonstrate"

Line 98: Line 98:
 
   </div>
 
   </div>
 
   <div class="column right">
 
   <div class="column right">
  <figure class="figures2">
 
 
   <div class="video-landscape">
 
   <div class="video-landscape">
 
   <video src="https://static.igem.org/mediawiki/2018/e/ee/T--NUS_Singapore-A--Results_Luteolin_Bioreactor.mp4" type="video/mp4" controls Autoplay=autoplay></video>
 
   <video src="https://static.igem.org/mediawiki/2018/e/ee/T--NUS_Singapore-A--Results_Luteolin_Bioreactor.mp4" type="video/mp4" controls Autoplay=autoplay></video>
 
</div>
 
</div>
       <figcaption>Bioreactor in action!</figcaption>
+
      <figure>
 +
       <figcaption style="text-align:center;">Bioreactor in action!</figcaption>
 
     </figure>
 
     </figure>
  

Revision as of 12:45, 17 October 2018

CONNECT WITH US
demonstrate header

We have developed a novel multicomponent biomanufacturing platform, Coup Dy’état, which serves to facilitate the optimization of biomanufacturing. From the various features that distinguish our system, to the heterologous production of compounds, we have successfully demonstrated that each part of our system works as intended. We have also shown how several of the components have been integrated into the biomanufacturing process.

XYLOSE AS FEEDSTOCK

✔ Successfully constructed an inducible xylose-utilizing module

Demonstrated improved growth of E. coli BL21* containing this module in xylose and glucose-xylose mixture

DE NOVO BIOSYNTHESIS

✔ Successfully constructed a naringenin-producing plasmid (with just a single missing enzyme) required for full de novo synthesis

Demonstrated the production of naringenin from coumaric acid in E. coli Acella and BL21*

LUTEOLIN

✔ Successfully constructed chemically-inducible and light inducible luteolin-producing plasmids

✔ Characterized expression of flavonoid 3′-hydroxylase (F3′H) under EL222 blue light repressible promoter PBLrep (Bba_K2819200)

✔ Characterized expression of flavonoid 3′-hydroxylase (FNS) under arabinose-inducible promoter PBAD (Bba_K2819206)

Demonstrated the production and extraction of luteolin from naringenin in E. coli BL21*, using shake-flask and bioreactor synthesis (see below)

BLUE LIGHT REPRESSIBLE SYSTEM

✔ Improved characterization of EL222 blue light repressible promoter PBLrep (BBa_K2819103)

Demonstrated blue light repressible control of luteolin production

STRESS REPORTER

✔ Successfully constructed a stress reporter module

✔ Characterized the burden-responsive promoter PhtpG1 (BBa_K2819010)

✔ Demonstrated that reporter is robust under across different genetic backgrounds and temperatures

Demonstrated that stress was induced by naringenin- and luteolin-producing plasmids, which was detected and reported by the stress reporter module

CELL-MACHINE INTERFACE

✔ Designed and built devices which help characterize optogenetic circuits in petri dishes and 250 ml conical flasks

✔ Designed and built a 500 ml working volume benchtop optogenetic bioreactor, which comprises a peristaltic pump, 2-in-1 OD and fluorescence sensor, and fermentation chamber

✔ Designed and implemented a feedback control system to control the optogenetic bioreactor

✔ Demonstrated the ability of 2-in-1 OD and fluorescence sensor to measure OD600 and fluorescence

Demonstrated the ability of the feedback control system to turn off blue light when fluorescence is detected





To bring ourselves one step closer to actual bioproduction, we scaled up our shake-flask biosynthesis to a 2 L bioreactor. After which, we also attempted to extract our target compound, luteolin, from the harvested sample.


Demo Image 04
Start of reaction

Demo Image 03
Process of extraction

Leong Minyi (actual fashion designer) Approved!

Bioreactor in action!

Demo Image 02
Harvested sample

Demo Image 04
The extracted product


Upon completion of the whole biomanufacturing process, we brought the product of our hard work back to one of the chief source of inspiration for Coup Dy'état, coming full circle for our project (see: Integrated Human Practices).